Johan Wedell-Wedellsborg - Jun 8, 2021 Form 4 Insider Report for Y-mAbs Therapeutics, Inc. (YMAB)

Role
Director
Signature
/s/ Johan Wedell-Wedellsborg
Stock symbol
YMAB
Transactions as of
Jun 8, 2021
Transactions value $
-$5,397,810
Form type
4
Date filed
6/10/2021, 06:35 PM
Previous filing
Jun 9, 2021
Next filing
Jun 14, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction YMAB Common Stock Sale -$1.17M -33.3K -0.77% $35.28* 4.31M Jun 8, 2021 By WG Biotech ApS F1, F3
transaction YMAB Common Stock Sale -$4.22M -117K -2.71% $36.19* 4.19M Jun 9, 2021 By WG Biotech ApS F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $34.50 to $35.85. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 This transaction was executed in multiple trades at prices ranging from $35.785 to $36.35. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 Reporting Person is the majority owner of WG Biotech ApS and as such has sole voting and dispositive power with respect to such shares.